Speaker illustration

Professor Tristan Mirault

PARCC INSERM U970 European Hospital Georges Pompidou APHP, Paris (France)

Member of:

European Society of Cardiology

Optimal pharmacotherapy

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session: Lower Extremity Artery Disease: improved management for better outcome

Thumbnail

Assessment of arterial damage in vascular Ehlers-Danlos syndrome: a retrospective multicentric cohort

Event: ESC Congress 2022

Topic: Peripheral Artery Disease

Session: Peripheral artery disease, COVID and rare vascular diseases

Thumbnail

Celiprolol to prevent arterial events in patients with vascular Ehlers-Danlos and neither symptomatic nor silent arterial event. A retrospective cohort study from the French national reference center

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Medical management and risk factors

Thumbnail

Characteristics of upper limb arterial involvement in thromboangeiitis obliterans patients

Event: ESC Congress 2018

Topic: Peripheral Artery Disease

Session: Peripheral artery disease: clinical

Thumbnail

Efficacy and potency of revascularisation in patients with thromboangiitis obliterans (Buerger disease)

Event: ESC CONGRESS 2017

Topic: Peripheral arterial disease

Session: Vascular diseases - 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk